Close Menu

EU

The company has begun a clinical trial for its Progensa PCA3 assay, enrolling 500 men who have had a negative prostate biopsy. The study is slated to complete in less than a year, at which point the company expects to submit its PMA to the FDA.

Roche's MRSA assay will compete against similar molecular tests from Cepheid and Becton Dickinson.

New Releases: Mar 25, 2009

Premium

DxS' TheraScreen KRAS Mutation Kit

Med BioGene's CEO said the company is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a CLIA-compliant partner lab.

DxS get EU approval to sell its TheraScreen K-RAS Mutation Kit for use on Roche's LightCycler instrument and licensed rights to related software.

Ten research entities will use almost $6 million to create a microbe resource that includes a DNA bank and provide high-throughput screening services.

Researchers in the Neuromuscular Disorder-Chip Consortium will use custom-designed NimbleGen Human CGH 12x135K microarrays and Human Sequence Capture 385K arrays to study the genetic underpinnings of a range of neuromuscular disorders.

The company will develop its HybSelect gene capturing technology for use in joint sequencing technology research.

BioArray Briefs: 2009.03.03

Premium

Febit, READNA Consortium, US Department of Agriculture, Autogenomics, Oxford Gene Technology, Optra, Gene Logic, Genstruct, Global Biomarker Conference

Short Reads: Mar 3, 2009

Premium

Febit, Complete Genomics, Broad Institute, EnGenCore, German Genetics Society, Albert Einstein College of Medicine, CLC Bio, Boehringer Ingelheim, Genomatix

Pages

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.